|
|
||||||||
1 Institut National de la Santé et de la Recherche Médicale (INSERM) U444, Equipe Biostat-Biomath, Université Paris 7-Denis Diderot, 75251 Paris Cedex 05; and 2 INSERM U337, Faculté de Médecine Broussais Hôtel-Dieu, 75270 Paris Cedex 06, France
| |
ABSTRACT |
|---|
|
|
|---|
Recent results in
normotensive Wistar-Kyoto (WKY) rats show that nonlinear method may be
more specific to quantify sympathetic and parasympathetic activities
than the low (LF) and high frequencies (HF) spectral powers of blood
pressure (BP) and R-R interval (RR). The present study extends this
conclusion to spontaneously hypertensive rats (SHR). Blood pressure was
recorded for 30 min before and after intravenous injection of saline,
hexamethonium, atropine, atenolol, or prazosin. Mean level, standard
deviation (SD), spectral LF and HF components, and three nonlinear
indexes (percentage of recurrence, percentage of determinism, and
length index of the recurrence plot method) were used to analyze the BP
and RR signals. In conscious SHR, sympathetic but not parasympathetic blockade reduced BP level and LF-BP, and increased nonlinear indexes of
BP. RR increased after
-sympathetic and ganglionic blockade, decreased after parasympathetic blockade, and remained unchanged after
1-sympathetic blockade. SD-RR decreased after ganglionic and
1 blockade, whereas HF-RR increased after
-sympathetic blockade. The effects on nonlinear indexes of RR are
clear and consistent: only
1-blockade increased the
indexes. Our nonlinear indexes may be useful to investigate
cardiovascular functions in normotension and hypertension.
recurrence plot; autonomic nervous system; cardiovascular control; spectral analysis; spontaneously hypertensive rats
| |
INTRODUCTION |
|---|
|
|
|---|
SINCE THE STUDY BY Akselrod et al. (4) was published in 1981, it has been suggested that the high-frequency (HF) component of heart rate spectral power may be a marker of parasympathetic tone, whereas the low-frequency (LF) component of blood pressure spectral power may be a good marker of the sympathetic activity. In contrast, the LF component of heart rate spectral power may reflect both sympathetic and parasympathetic activities (2, 25, 29). However, the use of these indexes as sympathetic and parasympathetic markers is still under debate (11, 15, 16, 18, 26, 31).
In recent studies, it has been argued that the mechanisms regulating
heart rate and blood pressure are most probably nonlinear (17, 34) and several authors (5, 24, 28,
33, 38-40) have used nonlinear techniques to analyze heart
rate and blood pressure series in healthy condition and in various
pathological states and have obtained reliable results. Dabiré et
al. (10) showed that in normotensive
Wistar-Kyoto (WKY) rats, ganglionic blockade by hexamethonium, and
1-sympathetic blockade by prazosin increased some
"nonlinear indexes" of blood pressure. In contrast, parasympathetic
blockade by atropine increased some nonlinear indexes of R-R interval
(RR). These results indicate that nonlinear methods might be useful to
explore the sympathetic and parasympathetic systems in the normotensive
rats. Nonlinear indexes were more specific markers of sympathetic and
parasympathetic tones than spectral indexes (10). The aim
of the present study was to investigate the relationships between the
same nonlinear indexes and autonomic system in spontaneously
hypertensive rats (SHR). We used the same protocol as in Ref.
10, which addressed to normotensive rats. In this study,
the sympathetic and/or parasympathetic systems were blocked by infusion
of atropine, hexamethonium, atenolol, or prazosin. Intra-arterial blood
pressure and heart rate were measured. Nonlinear indexes defined by the
recurrence plot (see METHODS for details) and spectral
indexes were analyzed in rats under drugs compared with rats under
neutral saline infusion.
| |
METHODS |
|---|
|
|
|---|
The experiments were performed in conscious, male SHR (Charles River France; St. Aubin-les-Elbeuf, France). The rats were received in the laboratory at 12 wk of age and were housed three per cage during 1 wk at 22-24°C, with lights on from 0600 to 1800 and pellets and water ad libitum.
The rats were randomized into five groups of six or seven rats each:
control group (NaCl 0.9%, 100 µl/kg iv, n = 7);
atropine group (atropine, 0.5 mg/kg iv, n = 6);
-blocking group (atenolol, 1 mg/kg iv, n = 6);
1-blocking group (prazosin, 1 mg/kg iv,
n = 6); and ganglion-blocked group (hexamethonium, 20 mg/kg iv, n = 6). The drugs were dissolved in saline;
doses refer to the salt.
The experimental procedure, animal surgery, blood pressure recording, and analysis have been described by Dabiré et al. (10). In brief, 2 days before blood pressure recording, the rats were anesthetized with pentobarbital sodium (60 mg/kg ip). Two polyethylene (PE) catheters [a PE-10 (ID 0.28 mm, OD 0.61 mm; Clay Adams, Parsippany, NJ) fused to a PE-50 (ID 0.58 mm, OD 0.96 mm; Guerbet; Louvres, France)] filled with heparinized 0.9% NaCl (50 U/ml) were inserted into the lower abdominal aorta via the left femoral artery and the left femoral vein for blood pressure recording and intravenous drug injection, respectively. The two catheters were tunneled subcutaneously under the skin of the back to exit between the scapulae and were plugged with a short piece of stainless steel wire. The rats were then allowed to recover from anesthesia for 48 h in individual cages. The two catheters were flushed twice daily with a solution of heparinized NaCl.
Recording of arterial pressure and intravenous injection of drugs were performed in unrestrained rats after the 2 days of recovery. The venous catheter was connected to a syringe for saline or drug injections. The arterial catheter was connected to a pressure processor via a pressure transducer (Statham model P23 ID, Gould Instruments; Longjumeau, France). After 60 min of stabilization, arterial blood pressure was recorded on an eight-channel digital audiotape recorder (model DTR-1800, Biologic; Claix, France). A series of two recordings (30 min each) was performed, the first one immediately after the 1-h period of stabilization. After that, saline or a drug was injected and, 20 min later, a second series (30 min) of recording was performed. Each rat received a single injection of saline or a drug. Injections were flushed with 30 µl of saline. At the end of the second series of 30-min recording the rat was euthanized.
The two 30-min blood pressure signal periods were sampled at 1 kHz through the digital audio tape recorder by a MacLab system (ADInstruments; London, UK). From this blood pressure wave, local maxima [systolic blood pressure (SBP)], local minima [diastolic blood pressure (DBP)], and time intervals from systolic-to-systolic blood pressure (RR) were computed. Each 30-min record afforded a series of 8,000-12,000 beat-to-beat SBP and DBP. SBP and DBP outside the range of 60-300 and 30-250 mmHg, respectively, were considered artifacts; <1% of values were in that group. To handle artifacts, a moving window of 200 values was screened along the series. In each window, we computed the mean value and SD of SBP and DBP. Whenever an artifactual SBP or DBP was encountered, the values of SBP or DBP were replaced by the mean of the windows.
We used a package of personal programs based on the formulas of Anderson (7) for Fourier analysis of blood pressure and RR. We calculated the total area under the Fourier spectrum and the percentage of this area in the LF band (0.25-0.75 Hz) and HF band (0.75-2.56 Hz) (8).
Nonlinear indexes were defined by the recurrence plot method (24,
38, 39). To explain the recurrence plot method, let us consider
an example. Given a series of length N, the recurrence plot
method looks for recurrent values in the series and records these
recurrences in an N × N square plot. Two values
in this series, Xi and Xj
(where i and j run from 1 to N), are
recurrent if their mutual distance is less than a threshold
r, Xi
Xj < r. If
Xi and Xj are recurrent,
we draw a black pixel at the location [i,j]. The
plot is symmetrical to the diagonal line; therefore, only one-half of
the figure is plotted with the diagonal excluded. Of particular
interest are the diagonal segments of length k in the plot:
when a recurrence is found at Xi and
Xj, the trajectories issued from
Xi and Xj remain parallel
for k subsequent beats.
Figure 1A, as an example,
shows a series of 10 SBP (×1, ×2, ×3, ..., ×10). Take
r = 2 to define the distance
threshold. We see that ×7 is recurrent to ×1. Furthermore, the
subsequent points, ×8, ×9, and ×10, are recurrent to ×2, ×3, and
×4, respectively. To mark these recurrences, we plotted in Fig.
1B the points [1,7]-[2,8]-[3,9]-[4,10]. These points
form a diagonal line. If several long diagonal lines are observed, this
means that sequences of data issued from similar levels remain long
time parallel. We say that the dynamic is highly deterministic. From
the plot, we computed three indexes: 1) the percentage of
recurrence (%rec), which counts the percentage of black pixels in the
plot; 2) the percentage of determinism (%det), which counts
the percentage of black pixels that are in diagonal segment of length
>2; 3) Lmax, the length of the
longest diagonal segment; Lmax is inversely
related to the highest "Lyapunov exponent," a measure of divergence
of trajectories (39). In Fig. 1A, we have
%rec = (4 + 2)/(9 × 10/2) = 0.12, %det = (3)/(4 + 2) = 0.50, and
Lmax = 4. Figure 1, C and
E, show the SBP series from a SHR treated with solvent or
prazosin, respectively. Figure 1, D and F, show
the recurrence plot for a series of 250 data.
|
In fact, the effective calculations are more complex: as in our
previous work (10), we embedded the series in a
p-dimensional Euclidian space, using the time-delay
reconstruction of Takens. The recurrence threshold r was set
as r = 
The results are expressed as means ± SE. Student's t-test for paired comparisons was used to assess the drug effects. One-way analysis of variance, followed by a Bonferroni test for multiple comparisons was used to compare baselines values in SHR (22). Comparisons between WKY and SHR were performed with the use of two-way analysis of variance, followed by a Bonferroni correction for multiple comparisons, yielding strain effect, treatment effect, and interaction. P < 0.05 was considered statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Baseline values of DBP, SBP, and RR, and their linear and nonlinear indexes did not differ in the five groups of SHR used. Intravenous administration of the solvent did not change any of these parameters.
Effects of autonomic blockade on linear indexes.
Figure 2 shows the effects of the
treatments on blood pressure, RR, and their SDs. Although both
hexamethonium and prazosin significantly (P < 0.001 for both) reduced DBP, only prazosin significantly (P < 0.01) decreased SD-DBP. Atenolol and atropine did not change DBP and
its SD. Similar results were observed on SBP and SD-SBP. Atenolol
significantly (P < 0.001) increased RR but did not
change its SD. In contrast, hexamethonium significantly (P < 0.05) increased RR but reduced SD-RR
(P < 0.01). Atropine reduced RR (P < 0.05) but did not change its SD. In contrast, prazosin did not change
RR but decreased SD-RR (P < 0.01).
|
|
Effects of autonomic blockade on nonlinear indexes.
Figure 4 shows the effects of the
treatments on the three nonlinear indexes of blood pressure and RR.
Hexamethonium and prazosin significantly increased %rec, %det, and
Lmax of DBP (P < 0.01 for all
treatments on all indexes, except P < 0.05 for
hexamethonium on %det). Similar results were observed on the nonlinear
indexes of SBP. Atenolol and atropine did not change nonlinear indexes of blood pressure. On RR, only prazosin significantly increased its
nonlinear indexes (P < 0.05 for %rec,
P < 0.01 for %det, and Lmax).
The other treatments did not change the nonlinear indexes of RR.
|
Comparisons between WKY rats and SHR.
Figure 5 shows the differences in
baseline values between WKY rats and SHR. Data on WKY rats are from
Dabiré et al. (10). SHR have higher DBP, SBP and
their SD (P < 0.001 for both) than WKY rats. Although
RR was also higher in SHR than in WKY rats (P < 0.001), no difference was observed in SD-RR between the two strains.
The LF components of DBP, SBP, and RR were significantly lower in SHR
than in WKY rats (P < 0.01, P < 0.01, and P < 0.05, respectively). In contrast, only the HF
component of SBP was lower (P < 0.001) in SHR than in
WKY rats. The nonlinear indexes (%rec, %det, and
Lmax) of DBP and SBP were significantly lower
(P < 0.001) in SHR than in WKY rats. In contrast, only
%rec-RR was lower (P < 0.05) in SHR than in WKY rats.
|
| |
DISCUSSION |
|---|
|
|
|---|
Table 1 summarizes the
results of the present study. In conscious SHR, sympathetic but not
parasympathetic blockade reduced blood pressure level, the LF component
of blood pressure power spectra and increased nonlinear indexes of
blood pressure. Although RR increased after
-sympathetic and
ganglionic blockade, it decreased after parasympathetic blockade, and
remained unchanged after
1-sympathetic blockade; SD of
RR decreased after ganglionic and
1-blockade, whereas
HF-RR increased after
-sympathetic blockade. The effects on
nonlinear indexes of RR are more homogenous because only
1-blockade increased them.
|
Our results show that in conscious SHR, sympathetic and parasympathetic
blockade induced the well-known effects on blood pressure and RR
levels. Indeed, ganglionic and
1-sympathetic, but not
-sympathetic, blockades significantly reduced blood pressure. Antonnacio et al. (8) have shown that
-adrenoceptor
blockade reduced blood pressure in conscious SHR provided that
sufficient time is allowed for this observation to occur, this effect
being unrelated to the acute changes in heart rate. On the other hand, the effects of hexamethonium on heart rate are species dependent and
hexamethonium does not adequately block the vagally mediated heart rate
in conscious rats (1). The lack of effect of prazosin on
RR may be ascribed to the putative central effects of
1-blockers (20), although this property
remains controversial (23).
Ganglionic blockade by hexamethonium and in particular
1-blockade by prazosin significantly reduced LF of blood
pressure, suggesting the participation of sympathetic tone, and more
specifically, the
-adrenergic component, in the LF component of the
blood pressure power spectrum. These results agree with those
suggesting the LF component of the blood pressure power spectrum as a
marker of sympathetic tone (9, 21, 30).
The participation of the parasympathetic system in the HF component of RR is less clear cut, because in our experiments, atropine did not change the HF component of the blood pressure power spectra. These results strengthened the conclusion that the indexes derived from spectral analysis could not be considered as specific markers of parasympathetic tone (11, 15, 16, 18, 19, 26, 31, 32).
Results obtained with nonlinear indexes are more clear cut than those
observed in the time and frequency domains. Parasympathetic blockade by
atropine and
-sympathetic blockade by atenolol did not change %rec,
%det, and Lmax of blood pressure or RR. These results ruled out the participation of the parasympathetic system and
that of the
-sympathetic component of the sympathetic system in the
modification of nonlinear indexes of blood pressure and RR. In
contrast, sympathetic blockade by hexamethonium and in particular
1-sympathetic blockade by prazosin, significantly increased both %rec, %det, and Lmax of blood
pressure, indicating the participation of the sympathetic tone and,
more specifically
1-sympathetic component, in the
changes of the three nonlinear indexes of blood pressure. Therefore,
our results suggest that nonlinear indexes of blood pressure may be
used as good markers of sympathetic tone.
The results obtained with nonlinear indexes of RR are more difficult to
discuss because only prazosin increased nonlinear indexes of RR. The
lack of effect of hexamethonium could be related to its inadequate
blockade of the vagal component at the ganglionic level
(1). On the other hand, our results are in concordance with those studies (17, 35, 41) showing that in rabbits and humans,
-adrenoceptor blockade did not change the highest Lyapunov exponent of heart rate.
Taken together our results clearly indicate the participation of
sympathetic nervous system, in particular
-sympathetic system, in
the modifications of nonlinear indexes of blood pressure. Thus in
contrast to the linear indexes derived from the spectral analysis, nonlinear indexes derived from recurrence plot method better reflect sympathetic tone.
Realized under the same experimental conditions as those already published (10) in WKY rats, the present results obtained in SHR allow us to perform comparisons between the two strains in term of baseline values and drugs effects. Baseline values of blood pressure and RR were higher and LF component of blood pressure and RR lower in SHR than in WKY rats. If we assume a dysbalance in the autonomic regulation of blood pressure in SHR, an increased sympathetic drive and/or decreased parasympathetic tone should be expected, with an increased blood pressure and heart rate as a result. Indeed, an increased sympathetic tone is commonly accepted in hypertension (6, 12, 13, 16). Therefore, sympathetic markers may increase in hypertension. However, although an increased level of blood pressure is reported (3, 27, 31) in SHR compared with WKY rats, no difference in heart rate is frequently observed between the two strains. Moreover, conflicting results have been reported on the linear markers of sympathetic activity, namely the LF of blood pressure and heart rate. Whereas Akselrod et al. (3) reported significantly lower low- and midfrequency fluctuations in blood pressure in SHR compared with WKY rats, others have shown no difference in the midfrequency power of blood pressure and heart rate (27, 31). The results of our experiments are thus in agreement with the precedent ones.
In a pharmacological point of view, results obtained in both SHR and
WKY rats suggest the implication of the sympathetic tone, and more
specifically, the
1-sympathetic component in the
modifications of nonlinear indexes of blood pressure. On the other
hand, although not directly related to the variance, the %rec may be
considered as a measure of the variability of the series, the higher
the %rec, the lower the variability of the series. The %det may be considered as an index of the predictability or regularity of the
dynamic. The higher the %det, the higher the dynamic is regular or can
be predicted. The length index Lmax is inversely
related to the highest Lyapunov exponent, allowing measurement of
divergence of trajectories. A high-Lyapunov exponent, i.e., a short
Lmax, expresses a "chaotic" dynamic. The
present results show that the nonlinear indexes of blood pressure were
lower in SHR than in WKY rats suggesting that the dynamic of blood
pressure in SHR is more chaotic than in WKY rats. In other words, the
dynamic of blood pressure is more variable (lower %rec), less
predictable (lower %det), and less sensitive to initial conditions
(lower Lmax) in SHR than in WKY rats. However,
this seems at variance with the increased periodicity associated with
increased regularity or predictability observed in some pathologic
conditions, such as severe congestive heart failure (14).
However, it might be relevant to note that most of the results
summarized in this review have been obtained in human and on heart rate
series. To our knowledge, little data are available on blood pressure
in animal. Moreover, Yip et al. (36, 37) observed almost
periodic oscillations of tubular pressure in the kidneys of normal
rats. The oscillations had more aperiodic character after arterial
clipping of one kidney and in SHRs. The results of our present study
were in the same direction as those of Yip et al. (37).
Therefore, it seems that the question whether physiological dynamics
are more or less chaotic in healthy status compared with some disease
status cannot be stated in a general manner. The answer depends on the
parameter analyzed, the type of pathology, the species, or both.
In conclusion, the present results indicate that compared with linear indexes, nonlinear indexes derived from the recurrence plot method may be useful quantitative tools to investigate cardiovascular functions in normotension as well as hypertension.
| |
ACKNOWLEDGEMENTS |
|---|
The authors gratefully acknowledge the technical assistance of Jacqueline Jarnet.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: D. Mestivier, INSERM U444, Equipe Biostat-Biomath, Courrier 7113, Université Paris 7-Denis Diderot, 75251 Paris Cedex 05, France (E-mail: mestiv{at}urbb.jussieu.fr).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 20 January 2000; accepted in final form 19 April 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Abdel-Rahman, ARA
Inadequate blockade by hexamethonium of the baroreceptor heart rate response in anesthetized and conscious rats.
Arch Int Pharmacodyn Ther
297:
68-85,
1989[ISI][Medline].
2.
Akselrod, S.
Spectral analysis of fluctuations in cardiovascular parameters: a quantitative tool for the investigation of autonomic control.
Trends Pharmacol Sci
9:
6-9,
1988[Medline].
3.
Akselrod, S,
Eliash S,
Oz O,
and
Cohen S.
Hemodynamic regulation in SHR: investigation by spectral analysis.
Am J Physiol Heart Circ Physiol
253:
H176-H183,
1987
4.
Akselrod, S,
Gordon D,
Ubel FA,
Shannon DC,
Barger AC,
and
Cohen RJ.
Power spectrum analysis of heart rate fluctuation: a quantitative probe for beat-to-beat cardiovascular control.
Science
213:
220-222,
1981
5.
Almog, Y,
Eliash S,
Oz O,
and
Akselrod S.
Nonlinear analysis of BP signal-can it detect malfunctions in BP control?
Am J Physiol Heart Circ Physiol
271:
H396-H403,
1996
6.
Anderson, EA,
Sinkey CA,
Lawton WJ,
and
Mark AL.
Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings.
Hypertension
14:
177-183,
1989
7.
Anderson, W.
The Statistical Analysis of Time Series. New York: Wiley, 1971, p. 92-136.
8.
Antonnacio, MJ,
High J,
Deforrest JM,
and
Sybertz E.
Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
J Pharmacol Exp Ther
238:
378-387,
1986
9.
Cerutti, C,
Gustin MP,
Paultre CZ,
Lo M,
Julien C,
Vincent M,
and
Sassard J.
Autonomic nervous system and cardiovascular variability in rats: a spectral analysis approach.
Am J Physiol Heart Circ Physiol
261:
H1292-H1299,
1991
10.
Dabiré, H,
Mestivier D,
Jarnet J,
Safar ME,
and
Chau NP.
Quantification of sympathetic and parasympathetic tones by nonlinear indexes in normotensive rats.
Am J Physiol Heart Circ Physiol
275:
H1290-H1297,
1998
11.
Daffonchio, A,
Franzelli C,
Radaelli A,
Castiglioni P,
Dirienzo M,
Mancia G,
and
Ferrari AU.
Sympathectomy and cardiovascular spectral components in conscious normotensive rats.
Hypertension
25:
1287-1293,
1995
12.
Esler, M,
Ferrier C,
Lambert G,
Eisenhofer G,
Cox H,
and
Jennings G.
Biochemical evidence of sympathetic hyperactivity in human hypertension.
Hypertension
17:
III29-III35,
1991.
13.
Folkow, B.
Physiological aspect of primary hypertension.
Physiol Rev
62:
343-504,
1982.
14.
Goldberger, AL.
Fractal variability versus pathologic periodicity: complexity loss and stereotypy in disease.
Perspect Biol Med
40:
543-561,
1997[ISI][Medline].
15.
Goldberger, JJ,
Ahmed MW,
Parker MA,
and
Kadish AH.
Dissociation of heart rate variability from parasympathetic tone.
Am J Physiol Heart Circ Physiol
266:
H2152-H2157,
1994
16.
Grassi, G,
and
Esler M.
How to assess sympathetic activity in humans.
J Hypertens
17:
719-734,
1999[ISI][Medline].
17.
Hagerman, I,
Berglund M,
Lorin M,
Nowak J,
and
Sylven C.
Chaos-related deterministic regulation of heart rate variability in time and frequency domains: effects of autonomic blockade and exercise.
Cardiovasc Res
31:
410-418,
1996[ISI][Medline].
18.
Hedman, AE,
Hartikainen JEK,
Tahvanainen KUO,
and
Hakumaki MOK
The high frequency component of heart rate variability reflects cardiac parasympathetic modulation rather than parasympathetic tone.
Acta Physiol Scand
155:
267-273,
1995[ISI][Medline].
19.
Houle, MS,
and
Billman GE.
Low-frequency component of the heart rate variability spectrum: a poor marker of sympathetic activity.
Am J Physiol Heart Circ Physiol
276:
H215-H223,
1999
20.
Huchet, AM,
Huguet F,
Ostermann G,
Brakri-Logeais F,
Schmitt H,
and
Narcisse G.
Central alpha1-adrenoceptors and cardiovascular control in normotensive and spontaneously hypertensive rats.
Eur J Pharmacol
95:
207-213,
1983[ISI][Medline].
21.
Japundzic, N,
Grichois ML,
Zitoun P,
Laude D,
and
Elghozi JL.
Spectral analysis of blood pressure and heart rate in conscious rats: effects of autonomic blockers.
J Auton Nerv Syst
30:
91-100,
1990[ISI][Medline].
22.
Kotz, S,
and
Johnson NL.
Encyclopedia of Statistical Sciences. New York: Wiley, 1985, p. 679-683.
23.
Laubie, M,
and
Schmitt H.
Prazosin produces a sustained and reflex-mediated increase in renal sympathetic activity in anesthetized dogs.
Eur J Pharmacol
151:
75-82,
1988[ISI][Medline].
24.
Mestivier, D,
Chau NP,
Chanudet X,
Bauduceau B,
and
Larroque P.
Relationship between diabetic autonomic dysfunction and heart rate variability assessed by recurrence plot.
Am J Physiol Heart Circ Physiol
272:
H1094-H1099,
1997
25.
Pagani, M,
Lombardi F,
Guzzetti S,
Rimoldi O,
Furlan R,
Pizzinelli P,
Sandrone G,
Malfatto G,
Dell'Orto S,
Piccaluga E,
Turiel M,
Baselli G,
Cerutti S,
and
Malliani A.
Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog.
Circ Res
59:
178-193,
1986
26.
Parati, G,
Saul JP,
Dirienzo M,
and
Mancia G.
Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation: a critical appraisal.
Hypertension
25:
1276-1286,
1995
27.
Persson, PB,
Stauss H,
Chung O,
Wittmann U,
and
Unger T.
Spectrum analysis of sympathetic nerve activity and blood pressure in conscious rats.
Am J Physiol Heart Circ Physiol
263:
H1348-H1355,
1992
28.
Pincus, SM.
Approximate entropy as a measure of system complexity.
Proc Natl Acad Sci USA
88:
2297-2301,
1990
29.
Pomeranz, B,
MacAulay RJB,
Caudill MA,
Kutz I,
Adam D,
Gordon D,
Kilborn KM,
Barger AC,
Shannon DC,
Cohen RJ,
and
Benson H.
Assessment of autonomic function in humans by heart rate spectral analysis.
Am J Physiol Heart Circ Physiol
248:
H151-H153,
1985
30.
Rimoldi, O,
Pierini S,
Ferrari A,
Cerutti S,
Pagani M,
and
Malliani A.
Analysis of short-term oscillations of R-R and arterial pressure in conscious dogs.
Am J Physiol Heart Circ Physiol
258:
H967-H976,
1990
31.
Stauss, HM,
Mrowka R,
Nafz B,
Patzak A,
Unger T,
and
Persson PB.
Does low frequency power of arterial blood pressure reflect sympathetic tone?
J Auton Nerv Syst
54:
145-154,
1995[ISI][Medline].
32.
Taylor, JA,
Williams TD,
Seals DR,
and
Davy KP.
Low-frequency arterial pressure fluctuations do not reflect sympathetic outflow: gender and age differences.
Am J Physiol Heart Circ Physiol
274:
H1194-H1201,
1998
33.
Wagner, CD,
Mrowka R,
Nafz B,
and
Persson PB.
Complexity and "chaos" in blood pressure after baroreceptor denervation of conscious dogs.
Am J Physiol Heart Circ Physiol
269:
H1760-H1766,
1995
34.
Wagner, CD,
and
Persson PB.
Nonlinear chaotic dynamics of arterial blood pressure and renal blood flow.
Am J Physiol Heart Circ Physiol
268:
H621-H627,
1995
35.
Yamamoto, Y,
and
Hughson RL.
On the fractal nature of heart rate variability in humans-effects of data length and
-adrenergic blockade.
Am J Physiol Regulatory Integrative Comp Physiol
266:
R40-R49,
1994
36.
Yip, KP,
and
Holstein-Rathlou NH.
Chaos and non-linear phenomena in renal vascular control.
Cardiovasc Res
31:
359-370,
1996[ISI][Medline].
37.
Yip, KP,
Holstein-Rathlou NH,
and
Marsh DJ.
Chaos in blood flow control in genetic and renovascular hypertensive rats.
Am J Physiol Renal Fluid Electrolyte Physiol
261:
F400-F408,
1991
38.
Zbilut, JP,
Koebbe M,
Loeb H,
and
Mayer-Kress G.
Use of recurrence plots in the analysis of heartbeat intervals.
In: Proceedings of IEEE Computers in Cardiology, edited by Muray A,
and Ripley KL.. Los Alamos, NM: IEEE Comput. Soc, 1991, p. 263-266.
39.
Zbilut, JP,
Webber CL, Jr,
and
Zak M.
Quantification of heart rate variability using methods derived from nonlinear dynamics.
In: Assessment and Analysis of Cardiovascular Function, edited by Drzewiecki G,
and Li JK-J.. New York: Springer-Verlag, 1998, p. 324-334.
40.
Zebrowski, JJ,
Poplawska W,
and
Baranowski R.
Entropy, pattern entropy, and related methods for the analysis of data on the time intervals between heartbeats from 24-h electrocardiograms.
Physiol Rev
50:
4188-4205,
1994.
41.
Zwiener, U,
Hoyer D,
Luthke B,
Schmidt K,
and
Bauer R.
Relations between parameters of spectral power densities and deterministic chaos of heart-rate variability.
J Auton Nerv Syst
57:
132-135,
1996[ISI][Medline].
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |